在帕金森病的治疗电生理学神经反方面
Elena Ubeda Matzilevich1, Pria Lauren Daniel2, Simon Little1
1Movement Disorders and Neuromodulation Division, Department of Neurology, University of California San Francisco, CA, USA.
Parkinsonism & related disorders
|January 20, 2024
概括
神经反 (NF) 帮助个人调节大脑活动,可能缓解帕金森病 (PD) 症状. 电生理学NF (epNF) 可能针对PD患者与运动和非运动问题相关的异常大脑节律.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 与病态神经振荡有关.
- 基本状皮质网络中过度的β振荡 (12-30 Hz) 与PD运动症状相关.
- 低频振荡 (1-12 Hz) 与PD非运动症状有关.
研究的目的:
- 审查电生理学神经反 (epNF) 治疗帕金森病运动和非运动症状的潜力.
- 探索epNF如何针对PD患者的特定神经振荡.
- 讨论epNF作为脑活动内源性自我调节的辅助疗法.
主要方法:
- 审查关于神经反和帕金森病的现有文献.
- 对证明epNF调节皮质和皮质下大脑节律的能力研究的分析.
- 检查神经活动的内源控制与行为变化之间的联系.
主要成果:
- 电生理学神经反 (epNF) 协议可以成功实现皮质和皮质下β节律的意志控制.
- 对β振荡的内源控制与运动行为的改善有关.
- epNF显示出理解和治疗PD运动和非运动症状的潜力.
结论:
- 电生理神经反 (epNF) 为帕金森病管理提供了一个有前途的途径.
- epNF可能使患者能够自我调节病态神经活动,解决运动和非运动症状.
- 对epNF的进一步研究可能会揭示帕金森病的新疗法策略.
相关概念视频
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551


